EUVIMEDEUVIMED entdecken
Crossref

Experimental Evidence for p-Coumaric Acid-Associated Attenuation of Chromium(VI)-Induced Oxidative Injury in HaCaT Keratinocytes

Ibrahim Gecili, Adem Güner, Ahmet Hacımüftüoğlu

Pharmata · 13.11.2026 · 6 (3) · 141-147

DOI: 10.62425/pharmata.1972367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmata, online erschienen am 13.11.2026. Verfasst von Ibrahim Gecili und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Chromium (VI) [Cr(VI)] is an environmental and occupational toxicant that may impair skin cell homeostasis through oxidative stress, membrane injury, and DNA fragmentation. p-Coumaric acid is a naturally occurring phenolic compound with reported antioxidant and cytoprotective properties. This study aimed to investigate whether p-coumaric acid attenuates Cr(VI)-induced cytotoxicity, oxidative imbalance, and DNA fragmentation in human HaCaT keratinocytes.

Methods

HaCaT cells were treated with p-coumaric acid at 10, 25, and 50 µM either alone or in combination with 50 µM K₂Cr₂O₇-derived Cr(VI) for 24 h. Cell viability, lactate dehydrogenase release, total antioxidant capacity, total oxidant status, malondialdehyde levels, superoxide dismutase activity, glutathione peroxidase activity, and DNA fragmentation were evaluated. Statistical analysis was performed using one-way analysis of variance followed by Tukey’s post hoc test.Results: p-Coumaric acid alone did not significantly affect cell viability, membrane integrity, oxidative stress parameters, antioxidant enzyme activities, or DNA fragmentation compared with the control group. Cr(VI) exposure markedly reduced cell viability and total antioxidant capacity, while increasing lactate dehydrogenase release, total oxidant status, malondialdehyde levels, and DNA fragmentation. It also decreased superoxide dismutase and glutathione peroxidase activities. Co-treatment with p-coumaric acid improved cell viability and antioxidant status and reduced membrane injury, oxidative burden, lipid peroxidation, and DNA fragmentation, with more pronounced effects at 25 and 50 µM.

Conclusion

These findings provide preliminary biochemical evidence that p-coumaric acid may attenuate Cr(VI)-induced oxidative and cytotoxic injury in HaCaT keratinocytes through changes associated with redox balance, membrane integrity, antioxidant enzyme activity, and DNA fragmentation. However, because direct ROS measurement, apoptosis-specific markers, and complementary DNA damage assays were not performed, further mechanistic studies are required to clarify the underlying pathways.

Zitieren

APA

Gecili, I., Güner, A., & Hacımüftüoğlu, A. (2026). Experimental Evidence for p-Coumaric Acid-Associated Attenuation of Chromium(VI)-Induced Oxidative Injury in HaCaT Keratinocytes. Pharmata, 6(3), 141-147. https://doi.org/10.62425/pharmata.1972367

Vancouver

Gecili I, Güner A, Hacımüftüoğlu A. Experimental Evidence for p-Coumaric Acid-Associated Attenuation of Chromium(VI)-Induced Oxidative Injury in HaCaT Keratinocytes. Pharmata. 2026;6(3):141-147. doi:10.62425/pharmata.1972367

BibTeX
@article{Gecili2026,
  author = {Gecili, Ibrahim and Güner, Adem and Hacımüftüoğlu, Ahmet},
  title = {Experimental Evidence for p-Coumaric Acid-Associated Attenuation of Chromium(VI)-Induced Oxidative Injury in HaCaT Keratinocytes},
  journal = {Pharmata},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {141--147},
  doi = {10.62425/pharmata.1972367}
}
Kostenlos starten →